| FSMAX | LBGAX | FSMAX / LBGAX | |
| Total Expense Ratio | 0.04 | 1.20 | 3% |
| Annual Report Gross Expense Ratio | 0.04 | 1.25 | 3% |
| Fund Existence | 15 years | 16 years | - |
| Gain YTD | 16.937 | 5.557 | 305% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 0 | 1000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 40.1B | 275M | 14,582% |
| Annual Yield % from dividends | 0.50 | 0.00 | - |
| Returns for 1 year | 23.68 | -2.36 | -1,006% |
| Returns for 3 years | 72.74 | 35.30 | 206% |
| Returns for 5 years | 40.14 | 0.98 | 4,081% |
| Returns for 10 years | 134.49 | 79.89 | 168% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| UX | 30.23 | 1.63 | +5.70% |
| Roundhill Uranium ETF | |||
| VSGX | 83.52 | 0.72 | +0.87% |
| Vanguard ESG International Stock ETF | |||
| BME | 46.13 | 0.33 | +0.72% |
| Blackrock Health Sciences Trust | |||
| IGA | 10.48 | 0.05 | +0.43% |
| Voya Global Advantage AND Premium Opportunity Fund | |||
| EMSF | 39.53 | -0.11 | -0.28% |
| Matthews Emerging Markets Sus Fut ActETF | |||